JNJ

Xarelto falls into the donut hole
Xarelto falls into the donut hole
Biopharma Dive
JNJ
Xarelto
Medicare
Flag link:
J&J (JNJ) Beats on Q2 Earnings, Ups 2019 Sales Growth View
J&J (JNJ) Beats on Q2 Earnings, Ups 2019 Sales Growth View
Yahoo/Zacks.com
JNJ
earnings
Flag link:
All eyes on Oklahoma as J&J awaits $17bn opioid case verdict
All eyes on Oklahoma as J&J awaits $17bn opioid case verdict
Pharmaforum
JNJ
opioids
opioid crisis
Oklahoma
Flag link:
J&J gears up for clinical test of HIV vaccine efficacy
J&J gears up for clinical test of HIV vaccine efficacy
Fierce Biotech
JNJ
clinical trials
HIV
vaccines
Flag link:
The Week Ahead In Biotech: Johnson & Johnson Kickstarts Big Pharma Earnings
The Week Ahead In Biotech: Johnson & Johnson Kickstarts Big Pharma Earnings
Yahoo/Benzinga
Merck
relebactam
TapImmune
earnings
JNJ
Seattle Genetics
Abbott Labs
Intuitive Surgical
Mirum Pharmaceuticals
Fulcrum Therapeutics
Genmab
Flag link:
Pharma Stock Roundup: Pipeline & Regulatory Updates by MRK, GSK, SNY
Pharma Stock Roundup: Pipeline & Regulatory Updates by MRK, GSK, SNY
Yahoo/Zacks.com
GSK
HIV
FDA
Merck
Keytruda
Sanofi
isatuximab
Roche
JNJ
Flag link:
J&J Stock Dives As Feds Reportedly Seek Criminal Probe Into Talc Powders
J&J Stock Dives As Feds Reportedly Seek Criminal Probe Into Talc Powders
Investors Business Daily
JNJ
Flag link:
J&J earnings preview: Wall Street is still optimistic despite company’s legal issues
J&J earnings preview: Wall Street is still optimistic despite company’s legal issues
Marketwatch
JNJ
earnings
Flag link:
Hunting better biomarkers, J&J taps Celsius to unpack role played by single cells
Hunting better biomarkers, J&J taps Celsius to unpack role played by single cells
Biopharma Dive
JNJ
Celsius Therapeutics
biomarkers
inflammatory bowel disease
Flag link:
Bayer/J&J eye new pediatric use for anticoagulant Xarelto
Bayer/J&J eye new pediatric use for anticoagulant Xarelto
Pharmaforum
Bayer
JNJ
Xarelton
pediatrics
Flag link:
J&J dumps Hanmi obesity drug following midphase trials
J&J dumps Hanmi obesity drug following midphase trials
Fierce Biotech
JNJ
HM12525A
obesity
Hanmi Pharmaceutical
Flag link:
FDA quickly approves J&J’s Darzalex in multiple myeloma
FDA quickly approves J&J’s Darzalex in multiple myeloma
Pharmaforum
JNJ
Janssen
FDA
Darzalex
Multiple Myeloma
Flag link:
J&J depression drug Spravato gets half-hearted backing from VA doctors despite Trump's zeal
J&J depression drug Spravato gets half-hearted backing from VA doctors despite Trump's zeal
Fierce Pharma
JNJ
Spravato
Veteran's Affairs
Donald Trump
depression
Flag link:
Cost-effectiveness watchdogs skewer Novartis' MS drug Mayzent and J&J's depression spray Spravato
Cost-effectiveness watchdogs skewer Novartis' MS drug Mayzent and J&J's depression spray Spravato
Fierce Pharma
Novartis
Mayzent
JNJ
Spravato
ICER
Flag link:
J&J's Ethicon and Spain's Grifols Release 1st Product Out of 10-Year Collaboration Deal
J&J's Ethicon and Spain's Grifols Release 1st Product Out of 10-Year Collaboration Deal
BioSpace
JNJ
Ethicon
Grifols
Vistaseal
surgical bleeding
Flag link:
Janssen’s guselkumab succeeds in phase 3 psoriatic arthritis trials
Janssen’s guselkumab succeeds in phase 3 psoriatic arthritis trials
Pharmaceutical Business Review
JNJ
Janssen
Tremfya
clinical trials
psoriatic arthritis
Flag link:
Janssen Eyes Another Approval for Tremfya After Hitting Trial Endpoints
Janssen Eyes Another Approval for Tremfya After Hitting Trial Endpoints
BioSpace
JNJ
Janssen
clinical trials
Tremfya
psoriatic arthritis
Flag link:
Johnson & Johnson takes a $4.8M hit in talc case, but once again pledges to appeal
Johnson & Johnson takes a $4.8M hit in talc case, but once again pledges to appeal
Fierce Pharma
JNJ
Flag link:
J&J gains an enthusiastic endorsement from President Donald Trump for their big new drug Spravato
J&J gains an enthusiastic endorsement from President Donald Trump for their big new drug Spravato
Endpoints
Donald Trump
JNJ
Spravato
depression
veterans
Flag link:
Fresh analysis spotlights cardio benefit of J&J's Invokana in diabetes patients without history of CV disease
Fresh analysis spotlights cardio benefit of J&J's Invokana in diabetes patients without history of CV disease
Endpoints
JNJ
Invokana
ADA
diabetes
cardiovascular disease
Flag link:

Pages